"Eicosanoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds named after and generally derived from C20 fatty acids (EICOSANOIC ACIDS) that includes PROSTAGLANDINS; LEUKOTRIENES; THROMBOXANES, and HYDROXYEICOSATETRAENOIC ACIDS. They have hormone-like effects mediated by specialized receptors (RECEPTORS, EICOSANOID).
| Descriptor ID |
D015777
|
| MeSH Number(s) |
D10.251.355.255 D23.469.050.175
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Eicosanoids".
Below are MeSH descriptors whose meaning is more specific than "Eicosanoids".
This graph shows the total number of publications written about "Eicosanoids" by people in this website by year, and whether "Eicosanoids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 4 | 2 | 6 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Eicosanoids" by people in Profiles.
-
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows. Clin Chem Lab Med. 2021 11 25; 59(12):1891-1905.
-
Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J Allergy Clin Immunol. 2021 08; 148(2):368-380.e3.
-
Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches. Int J Mol Sci. 2021 Feb 16; 22(4).
-
The need for precision nutrition, genetic variation and resolution in Covid-19 patients. Mol Aspects Med. 2021 02; 77:100943.
-
Bioactive lipids in antiviral immunity. Science. 2021 Jan 15; 371(6526):237-238.
-
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators. J Immunol. 2021 01 15; 206(2):329-334.
-
Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)? Am J Pathol. 2020 09; 190(9):1782-1788.
-
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020 06; 39(2):337-340.
-
Plasma Eicosanoid Profile in Plasmodium vivax Malaria: Clinical Analysis and Impacts of Self-Medication. Front Immunol. 2019; 10:2141.
-
Transcriptomic and lipidomic profiling of eicosanoid/docosanoid signalling in affected and non-affected skin of human atopic dermatitis patients. Exp Dermatol. 2019 02; 28(2):177-189.